Long-Term Interruption of Enzyme Replacement Therapy with rhGAA in Pompe Disease Leads to Irreversible Clinical Decline

Issue title: Abstracts from the 7th European Symposium on Steps Forward in Pompe Disease: Turin, Italy, November 21–22, 2014

Article type: Research Article

Authors: Hundsberger, Thomas | Rösler, Kai M. | Findling, Oliver

Affiliations: Department of Neurology, Cantonal Hospital, St. Gallen, Switzerland | Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland

Note: [] Correspondence to: Thomas Hundsberger, Department of Neurology, Cantonal Hospital, Rorschacherstr. 95, 9007 St. Gallen, Switzerland, Tel.: +41 71 494 3095; Fax: +41 71 494 2895; E-mail: thomas.hundsberger@kssg.ch

DOI: 10.3233/JND-159019

Journal: Journal of Neuromuscular Diseases, vol. 2, no. s1, pp. S20-S20, 2015